Imax (IMAX) Cash & Equivalents (2010 - 2026)

Imax's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $146.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 50.4% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $146.0 million (up 50.4% YoY), while the FY2025 annual figure was $151.2 million, up 50.28% from the prior year.
• Cash & Equivalents came in at $146.0 million for Q1 2026 at Imax, down from $151.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $162.3 million in Q1 2022 to a low of $76.2 million in Q4 2023.
• A 5-year average of $109.5 million and a median of $100.6 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents plunged 54.82% in 2022 and surged 50.4% in 2026, its largest moves.
• Imax's Cash & Equivalents stood at $97.4 million in 2022, then dropped by 21.77% to $76.2 million in 2023, then soared by 32.01% to $100.6 million in 2024, then jumped by 50.28% to $151.2 million in 2025, then slipped by 3.42% to $146.0 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $146.0 million, $151.2 million, and $143.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison